Zoekresultaten - 112 results
Intra- and interlaboratory reproducibility of the RIATOL qPCR HPV genotyping assay.
Results Uterine Cervical Neoplasms Abstract: The implementation of cervical screening based on human papillomavirus (HPV) continues to progress rapidly across countries. Evidence has shown that assays ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
Uterine Cervical Neoplasms Abstract: In 2017, cervical cancer screening in the Netherlands switched from cytology to human papillomavirus (HPV) testing using the validated PCR-based cobas 4800. Women could ...
Acceptability to Healthcare Professionals of Home-Based HPV Self-Sampling for Cervical Screening: A French Qualitative Study Conducted in an Area with Low Access to Health Services
Publication Type: Peer reviewed scientific article Authors: Le Goff, Johane; Le Duc-Banaszuk, Anne-Sophie; Lefeuvre, Caroline; Pivert, Adeline; Ducancelle, Alexandra; H De Pauw; M. Arbyn; Vinay, Aubeline; Rexand-Galais, Franck Source: Cancers, Volume 15, ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
papillomavirus (HPV) testing on self-samples represents a great opportunity to increase cervical cancer screening uptake among under-screened women. Methods A systematic review and meta-analysis on randomised ...
Vaccinatiegraad van basisvaccinaties
HPV ligt de nationale vaccinatiegraad voor volledige vaccinatie bij meisjes van 15 jaar (69,3%) lager dan de doelstelling van de WGO om baarmoederhalskanker te elimineren (≥ 90%). Health Topics: ...
Couverture vaccinale des vaccinations de base
vaccin rougeole-oreillons-rubéole, la couverture vaccinale dans les trois régions est inférieure au seuil de 95% recommandée par l’ OMS. Pour le HPV, le taux national de couverture vaccinale pour une ...
HPV and head and neck cancers: Towards early diagnosis and prevention.
viral infections, such as the mucosal high-risk (HR) human papillomaviruses (HPV s) are major risk factors for HNSCC development. In particular, HR HPV s are mainly associated with a subset of ...
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
Madhavan Radhakrishna; Sankaranarayanan, Rengaswamy; Bogers, Johannes; Pawlita, Michael; Tommasino, Massimo; M. Arbyn Source: BMC Infectious Diseases, Volume 22 (2022) Keywords: HPV DNA PCR; p16(INK4a) IHC; ...
Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework
clinically validated human papillomavirus (HPV) tests should be used in cervical cancer screening. VALGENT provides a framework to validate new HPV tests. In the VALGENT-3 study, the clinical accuracy of the ...